Cardiac amyloidosis (CA) leads to variable degrees of myocardial infiltration with a final echocardiographic phenotype of “hypertrophy.” Although many non-invasive imaging techniques (MRI, CT, scintigraphy, PET) are useful, the definitive diagnosis is still based on myocardial histology. We explored the possible role of [18F]-NaF PET/CT in the diagnosis of this disease in two cases with wild-type (ATTRwt) or mutant (ATTRm) Ile68Leu transthyretin (TTR)-related CA.
Titolo: | Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT? | |
Autore/i: | GAGLIARDI, CHRISTIAN; TABACCHI, ELENA; BONFIGLIOLI, RACHELE; DIODATO, STEFANIA; NANNI, CRISTINA; Guidalotti, Pierluigi; LORENZINI, MASSIMILIANO; LODI, FILIPPO; MILANDRI, AGNESE; RAPEZZI, CLAUDIO; FANTI, STEFANO | |
Autore/i Unibo: | ||
Anno: | 2017 | |
Rivista: | ||
Digital Object Identifier (DOI): | http://dx.doi.org/10.1007/s12350-016-0457-8 | |
Abstract: | Cardiac amyloidosis (CA) leads to variable degrees of myocardial infiltration with a final echocardiographic phenotype of “hypertrophy.” Although many non-invasive imaging techniques (MRI, CT, scintigraphy, PET) are useful, the definitive diagnosis is still based on myocardial histology. We explored the possible role of [18F]-NaF PET/CT in the diagnosis of this disease in two cases with wild-type (ATTRwt) or mutant (ATTRm) Ile68Leu transthyretin (TTR)-related CA. | |
Data stato definitivo: | 2016-11-09T13:11:40Z | |
Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.